scispace - formally typeset
F

Fabio Benfenati

Researcher at Istituto Italiano di Tecnologia

Publications -  424
Citations -  24243

Fabio Benfenati is an academic researcher from Istituto Italiano di Tecnologia. The author has contributed to research in topics: Synapsin & Synapsin I. The author has an hindex of 77, co-authored 406 publications receiving 21422 citations. Previous affiliations of Fabio Benfenati include University of Padua & University of Modena and Reggio Emilia.

Papers
More filters
Journal ArticleDOI

Fluorescence resonance energy transfer detection of synaptophysin I and vesicle-associated membrane protein 2 interactions during exocytosis from single live synapses.

TL;DR: It is proposed that synaptophysin I has multiple roles in neurotransmitter release, regulating VAMP2 availability for the soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex and possibly participating in the late steps of exocytosis.
Journal ArticleDOI

Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: the case of synapsins.

TL;DR: Deletion of single Syn genes in mice, in addition to epilepsy, causes core symptoms of ASD by affecting social behavior, social communication, and repetitive behaviors, and Syn knockout mice represent a good experimental model to define synaptic alterations involved in the pathogenesis of ASD and epilepsy.
Journal ArticleDOI

Synapsin Is a Novel Rab3 Effector Protein on Small Synaptic Vesicles I. IDENTIFICATION AND CHARACTERIZATION OF THE SYNAPSIN I-Rab3 INTERACTIONS IN VITRO AND IN INTACT NERVE TERMINALS

TL;DR: Observations strongly support a pre-docking role of the synapsins in the assembly and maintenance of a reserve pool of synaptic vesicles and suggest that thesynapsin-Rab3 interaction may participate in the regulation ofaptic vesicle trafficking within the nerve terminals.
Journal ArticleDOI

The evolution of artificial light actuators in living systems: from planar to nanostructured interfaces

TL;DR: Thiophene-based materials have allowed the development of a new generation of fully organic light actuators for in vivo applications that allow transduction of a light signal into a signal which in turn affects the biological activity of the hosting system.